These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36400537)

  • 21. Using novel magnetic resonance imaging methods to predict stroke risk in individuals with sickle cell anemia.
    Jordan LC; Kassim AA; Wilkerson KL; Lee CA; Waddle SL; Donahue MJ
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):76-84. PubMed ID: 32192979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium.
    Phillips S; Schlenz AM; Mueller M; Melvin C; Adams RJ; Kanter J;
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28569. PubMed ID: 32894002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How I treat and manage strokes in sickle cell disease.
    Kassim AA; Galadanci NA; Pruthi S; DeBaun MR
    Blood; 2015 May; 125(22):3401-10. PubMed ID: 25824688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How I manage cerebral vasculopathy in children with sickle cell disease.
    Brousse V; Kossorotoff M; de Montalembert M
    Br J Haematol; 2015 Sep; 170(5):615-25. PubMed ID: 25944412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurologic Complications of Sickle Cell Disease.
    Farooq S; Testai FD
    Curr Neurol Neurosci Rep; 2019 Feb; 19(4):17. PubMed ID: 30820687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Big strokes in small persons.
    Adams RJ
    Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroimaging in Sickle Cell Disease: A Review.
    Mallon D; Doig D; Dixon L; Gontsarova A; Jan W; Tona F
    J Neuroimaging; 2020 Nov; 30(6):725-735. PubMed ID: 33463866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke prevention and treatment in sickle cell disease.
    Adams RJ
    Arch Neurol; 2001 Apr; 58(4):565-8. PubMed ID: 11295986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sickle cell anemia: intracranial stenosis and silent cerebral infarcts in children with low risk of stroke.
    Arkuszewski M; Krejza J; Chen R; Ichord R; Kwiatkowski JL; Bilello M; Zimmerman R; Ohene-Frempong K; Melhem ER
    Adv Med Sci; 2014 Mar; 59(1):108-13. PubMed ID: 24797985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke.
    Carpenter JL; Nickel RS; Webb J; Khademian Z; Speller-Brown B; Majumdar S; Darbari DS; Campbell A; Zhang A; Abraham A
    Transplant Cell Ther; 2021 Dec; 27(12):1018.e1-1018.e9. PubMed ID: 34530179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimaging and Cognitive Function in Sickle Cell Disease: A Systematic Review.
    Abdi SS; De Haan M; Kirkham FJ
    Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis.
    Houwing ME; Grohssteiner RL; Dremmen MHG; Atiq F; Bramer WM; de Pagter APJ; Zwaan CM; White TJH; Vernooij MW; Cnossen MH
    BMC Med; 2020 Dec; 18(1):393. PubMed ID: 33349253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis.
    Prussien KV; Jordan LC; DeBaun MR; Compas BE
    J Pediatr Psychol; 2019 Sep; 44(8):948-958. PubMed ID: 31050352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease.
    Jordan LC; DeBaun MR
    J Cereb Blood Flow Metab; 2018 Sep; 38(9):1438-1448. PubMed ID: 28417646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcranial color Doppler in stroke-free adult patients with sickle cell disease.
    Graziadei G; Casoni FM; Annoni F; Cortinovis I; Ridolfi P; Gandolfi I; Marcon A; Di Pierro E; Cappellini MD
    Ann Hematol; 2017 Sep; 96(9):1547-1555. PubMed ID: 28730452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silent infarcts in young children with sickle cell disease.
    Kwiatkowski JL; Zimmerman RA; Pollock AN; Seto W; Smith-Whitley K; Shults J; Blackwood-Chirchir A; Ohene-Frempong K
    Br J Haematol; 2009 Aug; 146(3):300-5. PubMed ID: 19500105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain-derived neurotrophic factor levels in pediatric sickle cell disease.
    Lance EI; Barron-Casella E; Everett AD; Casella JF
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28076. PubMed ID: 31736231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurologic complications in children under five years with sickle cell disease.
    Galadanci AA; DeBaun MR; Galadanci NA
    Neurosci Lett; 2019 Jul; 706():201-206. PubMed ID: 31039424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.
    DeBaun MR; Jordan LC; King AA; Schatz J; Vichinsky E; Fox CK; McKinstry RC; Telfer P; Kraut MA; Daraz L; Kirkham FJ; Murad MH
    Blood Adv; 2020 Apr; 4(8):1554-1588. PubMed ID: 32298430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.